Projects

Laboratory based clinical validation of mDocTM wireless equipment in Healthy Indian Adults

Project Description

Librexia AF is a randomized, double-blind, double-dummy, parallel group, active-controlled study to evaluate the efficacy and safety of milvexian versus apixaban in participants with atrial fibrillation. Librexia AF is a randomized, double-blind, double-dummy, parallel group, active-controlled study to evaluate the efficacy and safety of milvexian versus apixaban in participants with atrial fibrillation.Librexia AF is a randomized, double-blind, double-dummy, parallel group, active-controlled study to evaluate the efficacy and safety of milvexian versus apixaban in participants with atrial fibrillation.

Project Duration

2014 - 2014

Project Lead

Dr. Tony Raj, Dr. Kedar Radhakrishna, Dr. Sejil

Authors

Dr. Tony Raj, Dr. Kedar Radhakrishna, Dr. Sejil

Project Status

completed

Project Type

Neurosynaptic Communications Pvt. Ltd.